Download PDF

Register to download the report. Already a member?

 
 
Sign Up

Or

63850 1504871583HCLSReviewHongKongSeptember2017.pdf
Energy Boardroom

Daiichi Sankyo joins norovirus vaccine race through UMN alliance

17.02.2014 / Scripintelligence

UMN will exclusively provide to its new partner a recombinant virus-like particle (VLP) antigen produced using baculovirus expression vector technology UMN has licensed for Asia from the US firm Protein Sciences. Daiichi Sankyo will carry out basic…

LATEST ISSUE

DOWNLOAD

X
Download PDF

First Name:

Last Name:

Company:

Position:

Country:

Email: